Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.13B
+42.0% from 2023
Prescriptions
1.4M
$789.66 per claim
Patients
367K
103,810 prescribers
Total spending, 2024
$1.13B
$3,078.85 per patient
Medicare prescription drug plans paid $1.13B for Breztri Aerosphere in 2024, for 1,430,708 prescriptions and refills to 366,942 patients (up 42.0% from 2023). The average cost per claim was $789.66.
Florida had the highest Medicare cost for Breztri Aerosphere in 2024: $94.5M for 111,902 claims, followed by Texas ($86.2M).
Jorge Sanchez-Masiques, pulmonary disease in Miami, FL, had the highest Medicare cost for Breztri Aerosphere in 2024: 1,712 claims costing $1.1M.
Breztri Aerosphere is made by AstraZeneca PLC (AZN), listed in the Medicare spending data as Astrazeneca.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jorge Sanchez-Masiques Miami, FL | Pulmonary Disease | 1,712 | 382 | $1.1M |
| Humam W Farah Hannibal, MO | Pulmonary Disease | 1,220 | 277 | $924K |
| Viren Desai |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 51,953 | 579,770 | 163,832 | $459.2M |
| 2023 | 76,504 | 954,478 | 257,744 | $795.5M |
| 2024 | 103,810 | 1,430,708 | 366,942 | $1.13B |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 798 |
| 224 |
| $734K |
| Huan A Le San Diego, CA | Pulmonary Disease | 1,159 | 213 | $707K |
| Yoel Brito Miami, FL | Pulmonary Disease | 1,007 | 233 | $686K |
| Hoang T Le Fountain Valley, CA | Pulmonary Disease | 1,025 | 171 | $685K |
| Kenneth K Sha Flushing, NY | Pulmonary Disease | 965 | 167 | $660K |
| Rafael A Martinez Tampa, FL | Pulmonary Disease | 897 | 255 | $638K |
| David N Pham Westminster, CA | Pulmonary Disease | 646 | 153 | $630K |
| Heidi A Berdin Lake Havasu City, AZ | Internal Medicine | 665 | 164 | $630K |
| Ahmad S Jalloul Clermont, FL | Pulmonary Disease | 735 | 227 | $627K |
| David R Clark Morganton, NC | Pulmonary Disease | 844 | 205 | $612K |
| Ernesto Mejia Morristown, TN | Pulmonary Disease | 784 | 205 | $590K |
| Azmi Draw Prospect, KY | Pulmonary Disease | 720 | 189 | $578K |
| Ladly Abraham Conway, AR | Pulmonary Disease | 771 | 179 | $573K |
| Milledge C Newton Jr. Valdosta, GA | Pulmonary Disease | 703 | 180 | $570K |
| Singwu D Law New York, NY | Pulmonary Disease | 817 | 130 | $548K |
| Steven W Harker Las Vegas, NV | Nurse Practitioner | 635 | 174 | $543K |
| Kari J Hill Grand Rapids, MI | Nurse Practitioner | 729 | 167 | $543K |
| Francis Torres Henderson, NV | Nurse Practitioner | 609 | 180 | $534K |
| Vivencio C Navarro Las Vegas, NV | Nurse Practitioner | 390 | 146 | $522K |
| Bharat Upadhyay Port St Lucie, FL | Pulmonary Disease | 549 | 158 | $513K |
| Hany S Aziz Bakersfield, CA | Pulmonary Disease | 759 | 175 | $503K |
| Ali El Atat Brooklyn, NY | Internal Medicine | 751 | 209 | $494K |
| Alec J Steils Waterloo, IA | Nurse Practitioner | 620 | 148 | $493K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Astrazeneca AZN | 1,431,108 | $1.13B |